Stability of melphalan solution for intravitreal injection for retinoblastoma

JAMA Ophthalmol. 2014 Nov;132(11):1372-3. doi: 10.1001/jamaophthalmol.2014.2324.

Authors

Emiliano Buitrago¹, Eduardo Lagomarsino², Gabriel Mato², Paula Schaiquevich³

Affiliations

¹ Clinical Pharmacokinetics Unit, Hospital de Pediatría J. P. Garrahan, Buenos Aires, Argentina.
² Department of Pharmacy, Hospital de Pediatría J. P. Garrahan, Buenos Aires, Argentina.
³ Clinical Pharmacokinetics Unit, Hospital de Pediatría J. P. Garrahan, Buenos Aires, Argentina3National Scientific and Technical Research Council (CONICET), Hospital de Pediatría J. P. Garrahan, Buenos Aires, Argentina.

PMID: 25078631
DOI: 10.1001/jamaophthalmol.2014.2324

No abstract available

MeSH terms

Antineoplastic Agents, Alkylating / administration & dosage
Antineoplastic Agents, Alkylating / chemistry*
Biological Availability
Chromatography, High Pressure Liquid
Drug Stability
Drug Storage
Humans
Intravitreal Injections
Melphalan / administration & dosage
Melphalan / chemistry*
Ophthalmic Solutions
Retinal Neoplasms / drug therapy*
Retinoblastoma / drug therapy*

Substances

Antineoplastic Agents, Alkylating
Ophthalmic Solutions
Melphalan